Clinical Trial
Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)
ClinicalTrials.gov7/6/2024·07/06/24🌐 USA
Summary
This trial evaluates the Boston Scientific Reclaim deep brain stimulation system for treatment-resistant obsessive-compulsive disorder. The implantable device delivers adjustable electrical stimulation to the ventral internal capsule and ventral striatum, with programming guided by patient response and symptom severity.
Why it matters
The Reclaim DBS system represents the newest generation of directional DBS technology for OCD. With improved electrode design and programming capabilities, this study could establish a new standard for invasive neuromodulation in patients who have exhausted all other treatment options.
#Phase 2#OCD#Deep Brain Stimulation#Neurostimulation#Neuroprosthetics#Mental Health Tech#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in